Table of Contents: Preface
The Effects of Benzodiazepines during Prolonged Administration and Under the Conditions of Stress;pp. 1-54
(Dubravka Svob Strac, Josipa Vlainic, Maja Jazvinscak Jembrek, Dorotea Muck-Seler, Nela Pivac, Rudjer Boskovic Institute, Division of Molecular Medicine, Laboratory of Molecular Neuropharmacology, Bijenicka, Zagreb, Croatia, and others)
Applying Benzodiazepine Discontinuation Strategies in Everyday Practice;pp. 55-74
(E. Mulkerrins, W. Cullen, D. Meagher, University of Limerick School of Medicine, Ireland)
Higher Side Actions of Benzodiazepines in the Elderly: Clinical and Basic Aspects;pp. 75-90
(Sandra Olvera-Hernández, Alonso Fernández-Guasti, Pharmacobiology Department, CINVESTAV, México City, México)
Risk Factors for Benzodiazepine Dependence in Women with Major Depression or Anxiety Disorders;pp. 91-102
(A. Fresán, C. Berlanga, R. Robles-García, O. Minaya, Subdirección de Investigaciones Clínicas. Instituto Nacional de Psiquiatría “Ramón de la Fuente Muníz”, Secretaría de Salud. Mexico City, Mexico, and others)
Flumazenil Slow-Infusion in the Treatment of High Dose Benzodiazepine Dependence;pp. 103-112
(Fabio Lugoboni, Marco Faccini, Rebecca Casari, Gianluca Quaglio, Addiction Unit,Verona University Hospital, Verona, Italy)
Encephalopathies Related to Exogenous or Endogenous Benzodiazepines;pp. 113-159
(Ron Granot, Institute of Neurosciences, Prince of Wales Hospital, University of New South Wales, Randwick, Australia)*
Benzodiazepine Withdrawal Syndrome and Strategies for Discontinuing Benzodiazepine Use: Appropriate Treatment with SSRIs and SNRIs;pp. 161-179
(Mutsuhiro Nakao, Kyoko Nomura, Takeaki Takeuchi, Department of Hygiene and Public Health, Teikyo University School of Medicine and Division of Psychosomatic Medicine, Teikyo University Hosptial, Tokyo, Japan)*
Index |